- Home
- TACO vs MBX Comparison
TACO vs MBX Comparison
Compare TACO & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACO
- MBX
- Stock Information
- Founded
- TACO 2024
- MBX 2018
- Country
- TACO United States
- MBX United States
- Employees
- TACO N/A
- MBX N/A
- Industry
- TACO Blank Checks
- MBX
- Sector
- TACO Finance
- MBX
- Exchange
- TACO Nasdaq
- MBX NYSE
- Market Cap
- TACO 389.8M
- MBX 379.7M
- IPO Year
- TACO 2025
- MBX 2024
- Fundamental
- Price
- TACO $10.67
- MBX $9.63
- Analyst Decision
- TACO
- MBX Strong Buy
- Analyst Count
- TACO 0
- MBX 5
- Target Price
- TACO N/A
- MBX $37.40
- AVG Volume (30 Days)
- TACO 431.5K
- MBX 227.0K
- Earning Date
- TACO 01-01-0001
- MBX 08-16-2025
- Dividend Yield
- TACO N/A
- MBX N/A
- EPS Growth
- TACO N/A
- MBX N/A
- EPS
- TACO N/A
- MBX N/A
- Revenue
- TACO N/A
- MBX N/A
- Revenue This Year
- TACO N/A
- MBX N/A
- Revenue Next Year
- TACO N/A
- MBX N/A
- P/E Ratio
- TACO N/A
- MBX N/A
- Revenue Growth
- TACO N/A
- MBX N/A
- 52 Week Low
- TACO $10.10
- MBX $4.81
- 52 Week High
- TACO $11.19
- MBX $27.50
- Technical
- Relative Strength Index (RSI)
- TACO N/A
- MBX N/A
- Support Level
- TACO N/A
- MBX N/A
- Resistance Level
- TACO N/A
- MBX N/A
- Average True Range (ATR)
- TACO 0.00
- MBX 0.00
- MACD
- TACO 0.00
- MBX 0.00
- Stochastic Oscillator
- TACO 0.00
- MBX 0.00
About TACO Berto Acquisition Corp. Ordinary Shares
Berto Acquisition Corp is a blank check company.
About MBX MBX BIOSCIENCES INC
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.